Ongoing Citations of a Retracted Study Involving Cardiovascular Disease, Drug Therapy, and Mortality in COVID-19

JAMA Intern Med. 2021 Nov 1;181(11):1535-1537. doi: 10.1001/jamainternmed.2021.4112.

Authors

Todd C Lee^{1

2}, Julien Senecal³, Jimmy M Hsu³, Emily G McDonald^{2

4}

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, McGill University, Montréal, Quebec, Canada.
² Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada.
³ Faculty of Medicine and Health Sciences, McGill University, Montréal, Quebec, Canada.
⁴ Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada.

Abstract

This quality improvement study examines the continued citations of a widely publicized retracted article on COVID-19.

Publication types

Letter

MeSH terms

COVID-19 / complications*
COVID-19 / mortality
COVID-19 Drug Treatment*
Cardiovascular Diseases / etiology*
Humans
Hydroxychloroquine / therapeutic use*
Publishing / statistics & numerical data*
Retraction of Publication as Topic*

Substances

Hydroxychloroquine